64
Growth Score
pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
796570
Dendrogenix develops innovative drugs based on Dendrogenins to treat deafness, cancer, and neurological diseases.
- Emile Loria: Co-Founder and Chairman
About the Company
Dendrogenix is a biopharmaceutical company that focuses on developing innovative drugs based on Dendrogenins. These small molecules are designed to address high unmet medical needs, particularly in the areas of deafness and cancer. The company aims to create first-in-class molecules to provide new therapeutic options for patients suffering from
these conditions. Dendrogenix's research and development efforts are centered on leveraging the unique properties of Dendrogenins to develop effective treatments for hearing loss and neurological diseases.
